Low density lipoprotein landmark trials: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 8: | Line 8: | ||
{| style="font-size:120%" | {| style="font-size:120%" | ||
|- | |- | ||
| WOSCOPS ([[pravastatin]]) | | [[WOSCOPS Trial]] ([[pravastatin]]) | ||
|- | |- | ||
| AFCAPS/TexCAPS ([[lovastatin]]) | | [[AFCAPS/TexCAPS Trial]] ([[lovastatin]]) | ||
|- | |- | ||
| [[4S Trial]] ([[simvastatin]]) | | [[4S Trial]] ([[simvastatin]]) | ||
|- | |- | ||
| Heart Protection Study ([[simvastatin]]) | | [[Heart Protection Study]] ([[simvastatin]]) | ||
|- | |- | ||
| ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial ([[pravastatin]]) | | [[ALLHAT]]: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial ([[pravastatin]]) | ||
|- | |- | ||
| PROSPER: Prospective Study of [[pravastatin]] in the Elderly at Risk ([[pravastatin]]) | | [[PROSPER Trial]]: Prospective Study of [[pravastatin]] in the Elderly at Risk ([[pravastatin]]) | ||
|- | |- | ||
| ASCOT-LLA: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm ([[atorvastatin]]) | | [[ASCOT-LLA Trial]]: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm ([[atorvastatin]]) | ||
|- | |- | ||
| PROVE IT: [[pravastatin]] or [[atorvastatin]] Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction ([[pravastatin]]) | | [[PROVE IT Trial]]: [[pravastatin]] or [[atorvastatin]] Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction ([[pravastatin]]) | ||
|- | |- | ||
| [[ASTEROID Trial]] ([[rosuvastatin]]) | | [[ASTEROID Trial]] ([[rosuvastatin]]) | ||
|- | |- | ||
| MEGA ([[pravastatin]]) | | [[MEGA]] ([[pravastatin]]) | ||
|- | |- | ||
| [[CORONA Trial]] ([[rosuvastatin]]) | | [[CORONA Trial]] ([[rosuvastatin]]) | ||
|- | |- | ||
| JUPITER ([[rosuvastatin]]) | | [[JUPITER Trial]] ([[rosuvastatin]]) | ||
|- | |- | ||
| [[SATURN Trial]] ([[atorvastatin]], [[rosuvastatin]]) | | [[SATURN Trial]] ([[atorvastatin]], [[rosuvastatin]]) | ||
Revision as of 03:12, 29 September 2014
|
Low Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Low density lipoprotein landmark trials On the Web |
|
American Roentgen Ray Society Images of Low density lipoprotein landmark trials |
|
Risk calculators and risk factors for Low density lipoprotein landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Landmark Trials
Statin
| WOSCOPS Trial (pravastatin) |
| AFCAPS/TexCAPS Trial (lovastatin) |
| 4S Trial (simvastatin) |
| Heart Protection Study (simvastatin) |
| ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (pravastatin) |
| PROSPER Trial: Prospective Study of pravastatin in the Elderly at Risk (pravastatin) |
| ASCOT-LLA Trial: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (atorvastatin) |
| PROVE IT Trial: pravastatin or atorvastatin Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction (pravastatin) |
| ASTEROID Trial (rosuvastatin) |
| MEGA (pravastatin) |
| CORONA Trial (rosuvastatin) |
| JUPITER Trial (rosuvastatin) |
| SATURN Trial (atorvastatin, rosuvastatin) |
Multiple Lipid Lowering Drugs
| HARP Study |